Image source: Getty Images.
Endo International (NASDAQ: ENDP) is up 15% at 3:17 p.m. EDT after the drugmaker announced that Paul Campanelli is taking over as president and CEO.
Campanelli, who was previously the president of Par Pharmaceuticals — Endo’s generic and OTC drugs business — takes over for Rajiv De Silva. Campanelli was CEO of Par Pharmaceuticals before Endo acquired the company, so he has experience at the top.